Published in Biotech Business Week, February 20th, 2006
He oversees Exagen's day-to-day operations, as well as company alliances. Exagen CEO Jim McClintic, who joined the company in October, will continue to guide the company's strategic direction.
"Our mission is to focus innovative genomic and computational science on creating leading-edge markers and tests that individualize patient care worldwide," said McClintic. "Bob's expertise in business development and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.